Preparation method and application of recombinant human leucocyte interleukin 27
A technology of interleukin and insect cells, which is applied in the field of preparation of recombinant human interleukin 27 and can solve the problems of HBV drug resistance and the like
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0026] Example 1 Preparation of recombinant human interleukin 27
[0027] (1) Cloning of human interleukin 27 gene: using the total mRNA extracted from human blood leukocytes as a template, first amplify the total cDNA by reverse transcription RCR, and then use the cDNA as a template to amplify the complete IL with specific primers Two gene fragments of -27 (EBI3 fragment and P28 fragment); among them, the primer P1 (forward primer) used for the EBI3 fragment: 5'-GGAATTCATG
[0028] AGGAAAGGGCCCCCAGC-3', P2 (reverse primer): 5'-CAAGCTTTTAGTGGTGGTGGTGGTG
[0029]GTGGGAACCCTTGCCCAGGCTCATTGTGG-3', introduce EcoRI and HindIII restriction sites, and clone it into the PH promoter of the vector pFASTbac-dual; primer P3 (forward primer) for the P28 fragment: 5'-CCTCGAGATGTTCCCAAGGCCCCCAG-3', P4 (reverse Primer): 5'-GGCATGCTTAGTGGT
[0030] GGTGGTGGTGGTGGGAACCGGGCTGGGGGCTCAATGT-3', XhoI and SphI restriction sites were introduced, and it was cloned under the P10 promoter of the vector...
Embodiment 2
[0035] Example 2 Recombinant human interleukin 27 inhibits the expression of hepatitis B virus HBsAg and HBeAg
[0036] Add the cultured HepG2.2.15 cell recombinant human interleukin 27 to HepG2.2.15 cells, 0.1 μg / well in 24-well plate, set at 37°C, 5% CO 2 After 24 hours of cultivation in the incubator, the expression levels of HBsAg and HBeAg were detected with the hepatitis B virus surface antigen diagnostic kit and hepatitis B virus e antigen diagnostic kit (purchased from Shanghai Kehua Bioengineering Co., Ltd.). The results showed that the HBsAg level decreased by 65.7%, and the HBeAg level decreased by 74.1%.
Embodiment 3
[0037] Example 3 Recombinant human interleukin 27 inhibits the replication of hepatitis B virus
[0038] Add recombinant human interleukin 27 to HepG2.2.15 cells, 0.1 μg / well in 24-well plate, set at 37°C, 5% CO 2 After culturing in the incubator for 24 hours, the hepatitis B virus (HBV) nucleic acid amplification (PCR) fluorescence quantitative detection kit (the detection kit was purchased from Shenzhen Piji Biological Engineering Co., Ltd.) was used to detect the HBV linked to the nucleocapsid. Hepatitis virus genomic DNA, primers P5: 5'-ATCCTGCTGCTATGCCTCATCTT-3' and P6: 5'-ACAGTGGGGAAAGCCCT
[0039] ACGAA-3', probe: 5'-TGGCTAGTTTACTAGTGCCATTTTG-3', reaction conditions: 50°C for 2 minutes, 95°C for 10 minutes, 95°C for 15 seconds, 60°C for 60 seconds for 40 cycles. The results showed that the level of cccDNA decreased by 55.2%.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com